GlassScriptPhysician profile
Milan A Kothari
NPI 1740282037
$10,189.36
in general payments reported to CMS, 2019-2025
42 companies · $893 in 2025
The $893 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $1,085 · 2021: $1,951 · 2022: $1,775 · 2023: $1,671 · 2024: $1,752 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,316.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,486.79 | 2019-2024 | Xarelto |
| Amgen INC. | $1,016.80 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $816.22 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $748.51 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $605.65 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $562.43 | 2021-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $540.31 | 2024-2025 | Assure Wcd |
| Amarin Pharma, INC. | $515.19 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $468.36 | 2019-2025 | Lifevest |
| Abiomed | $441.58 | 2024-2025 | Impella |
| Esperion Therapeutics, INC. | $303.58 | 2020-2023 | Nexletol |
| Bard Peripheral Vascular, INC. | $274.12 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $229.79 | 2022-2023 | Opsumit, Uptravi |
| Boston Scientific Corporation | $228.17 | 2019-2021 | |
| Heartflow, INC. | $214.84 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $204.85 | 2021-2025 | Cardiomems, Ensite Precision |
| Impulse Dynamics (USA) INC. | $179.25 | 2023 | Optimizer |
| Pfizer INC. | $171.05 | 2019-2025 | |
| Cvrx, INC. | $122.68 | 2022-2023 | Barostim Neo System |
| Novo Nordisk INC | $113.85 | 2024 | Wegovy |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Portola Pharmaceuticals, LLC | $83.52 | 2019-2020 | |
| Tactile Systems Technology INC | $81.72 | 2019-2021 | |
| Baxter Healthcare | $78.11 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Atricure, INC. | $64.66 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Lexicon Pharmaceuticals, INC. | $61.63 | 2023-2024 | Inpefa |
| Gilead Sciences, INC. | $49.20 | 2019 | |
| Acacia Pharma INC | $43.77 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $43.36 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $42.56 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $42.35 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $39.76 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.83 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $36.90 | 2019 | |
| Biotronik INC. | $36.32 | 2019 | |
| Lundbeck LLC | $22.71 | 2019 | |
| Bardy Diagnostics, INC. | $22.50 | 2020 | |
| Elutia, INC. | $15.49 | 2022 | |
| Scpharmaceuticals INC. | $15.40 | 2024 | |
| Allergan, INC. | $13.71 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Cashflow Solutions, LLC | $0.40 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milan Kothari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.